Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

COGSCREEN II: Early Detection of Cognitive Impairment — Stella

Home/Alzheimer's Disease (AD)/COGSCREEN II: Early Detection of Cognitive Impairment

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer's Disease (AD) trials

COGSCREEN II: Early Detection of Cognitive Impairment

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

Klinik für Psychiatrie und Psychotherapie am LMU Klinikum, München

Key details

Sponsor

Robert Perneczky

Collaborators

Davos Alzheimer's Collaborative

Enrollment target

~400 participants

Started

June 2025

Primary completion

July 2027

Age range

60 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.